Literature DB >> 26604941

Rare causes of osteoporosis.

Gemma Marcucci1, Maria Luisa Brandi1.   

Abstract

Osteoporosis is a metabolic bone disease characterized by loss of bone mass and strength, resulting in increased risk of fractures. It is classically divided into primary (post-menopausal or senile), secondary and idiopathic forms. There are many rare diseases, that cause directly or indirectly osteoporosis. The identification and classification of most of these rare causes of osteoporosis is crucial for the specialists in endocrinology and not, in order to prevent this bone complication and to provide for an early therapy. Several pathogenic mechanisms are involved, including various aspects of bone metabolism such as: decreased bone formation, increased bone resorption, altered calcium, phosphorus and/or vitamin D homeostasis, and abnormal collagen synthesis. In this review, less common forms of primary and secondary osteoporosis are described, specifying, if applicable: genetic causes, epidemiology, clinical features, and pathogenic mechanisms causing osteoporosis. A greater awareness of all rare causes of osteoporosis could reduce the number of cases classified as idiopathic osteoporosis and allow the introduction of appropriate and timely treatments.

Entities:  

Keywords:  osteoporosis; rare disease; secondary osteoporosis

Year:  2015        PMID: 26604941      PMCID: PMC4625772          DOI: 10.11138/ccmbm/2015.12.2.151

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  69 in total

1.  Bisphosphonates in pregnancy and lactation-associated osteoporosis.

Authors:  S M O'Sullivan; A B Grey; R Singh; I R Reid
Journal:  Osteoporos Int       Date:  2006-04-27       Impact factor: 4.507

2.  Skeletal mineralization defects in adult hypophosphatasia--a clinical and histological analysis.

Authors:  F Barvencik; F Timo Beil; M Gebauer; B Busse; T Koehne; S Seitz; J Zustin; P Pogoda; T Schinke; M Amling
Journal:  Osteoporos Int       Date:  2011-01-26       Impact factor: 4.507

3.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

4.  Prevalence of human GH-1 gene alterations in patients with isolated growth hormone deficiency.

Authors:  J K Wagner; A Eblé; P C Hindmarsh; P E Mullis
Journal:  Pediatr Res       Date:  1998-01       Impact factor: 3.756

5.  Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression.

Authors:  Mario Pescatori; Aldobrando Broccolini; Carlo Minetti; Enrico Bertini; Claudio Bruno; Adele D'amico; Camilla Bernardini; Massimiliano Mirabella; Gabriella Silvestri; Vincenzo Giglio; Anna Modoni; Marina Pedemonte; Giorgio Tasca; Giuliana Galluzzi; Eugenio Mercuri; Pietro A Tonali; Enzo Ricci
Journal:  FASEB J       Date:  2007-01-30       Impact factor: 5.191

6.  Bone metabolism in galactosemia.

Authors:  B Panis; P Ph Forget; M J P G van Kroonenburgh; C Vermeer; P P Menheere; F H Nieman; M E Rubio-Gozalbo
Journal:  Bone       Date:  2004-10       Impact factor: 4.398

Review 7.  Cystic fibrosis-related bone disease.

Authors:  Julien Paccou; Patrice Fardellone; Bernard Cortet
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

Review 8.  Gaucher disease: a comprehensive review.

Authors:  Barry E Rosenbloom; Neal J Weinreb
Journal:  Crit Rev Oncog       Date:  2013

9.  Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis.

Authors:  J Ambroszkiewicz; D Sands; J Gajewska; M Chelchowska; T Laskowska-Klita
Journal:  Adv Med Sci       Date:  2013       Impact factor: 3.287

Review 10.  Osteoporosis in primary biliary cirrhosis of the liver.

Authors:  Joanna Raszeja-Wyszomirska; Tomasz Miazgowski
Journal:  Prz Gastroenterol       Date:  2014-05-05
View more
  14 in total

1.  Interleukin-6 as possible early marker of stress response after femoral fracture.

Authors:  Goran Pesic; Jovana Jeremic; Tamara Nikolic; Vladimir Zivkovic; Ivan Srejovic; Aleksandra Vranic; Jovana Bradic; Branko Ristic; Aleksandar Matic; Nikola Prodanovic; Vladimir Jakovljevic
Journal:  Mol Cell Biochem       Date:  2017-02-16       Impact factor: 3.396

2.  Association of Hypertension and Lipid Profile with Osteoporosis.

Authors:  Mohammed Al-Hariri; Bander Aldhafery
Journal:  Scientifica (Cairo)       Date:  2020-07-12

3.  Frequency, diagnosis, pathogenesis and management of osteoporosis in alkaptonuria: data analysis from the UK National Alkaptonuria Centre.

Authors:  L R Ranganath; M Khedr; S Vinjamuri; J A Gallagher
Journal:  Osteoporos Int       Date:  2020-10-29       Impact factor: 4.507

4.  Potential cause affecting bone quality in Saudi Arabia: New insights.

Authors:  Mohammed T Al-Hariri; Roaa Al Goweiz; Bander Aldhafery; Majed M Alsadah; Ahmed S Alkathim; Mohsen Z AlQassab; Abdullah H AlRammadan; Mahmoud A AlElaq
Journal:  J Family Med Prim Care       Date:  2021-01-30

5.  Relation between phalangeal bone mineral density and radiographic knee osteoarthritis: a cross-sectional study.

Authors:  Zhen-Han Deng; Chao Zeng; Yu-Sheng Li; Tuo Yang; Hui Li; Jie Wei; Guang-Hua Lei
Journal:  BMC Musculoskelet Disord       Date:  2016-02-11       Impact factor: 2.362

Review 6.  Circulating miRNAs: A New Opportunity in Bone Fragility.

Authors:  Simone Donati; Simone Ciuffi; Gaia Palmini; Maria Luisa Brandi
Journal:  Biomolecules       Date:  2020-06-18

7.  Correlations between periodontal disease, mandibular inferior cortex index and the osteoporotic fracture probability assessed by means of the fracture risk assessment body mass index tool.

Authors:  Paweł Kalinowski; Ingrid Różyło-Kalinowska; Magdalena Piskórz; Urszula Bojakowska-Komsta
Journal:  BMC Med Imaging       Date:  2019-05-22       Impact factor: 1.930

8.  Blueberry Juice Antioxidants Protect Osteogenic Activity against Oxidative Stress and Improve Long-Term Activation of the Mineralization Process in Human Osteoblast-Like SaOS-2 Cells: Involvement of SIRT1.

Authors:  Vladana Domazetovic; Gemma Marcucci; Irene Falsetti; Anna Rita Bilia; Maria Teresa Vincenzini; Maria Luisa Brandi; Teresa Iantomasi
Journal:  Antioxidants (Basel)       Date:  2020-02-01

9.  A Case of Short Stature and Severe Osteoporosis in a Young Man with Oculocutaneous Albinism: Syndrome or Coincidence?

Authors:  Samson O Oyibo
Journal:  Cureus       Date:  2020-04-24

10.  Enhancer variants reveal a conserved transcription factor network governed by PU.1 during osteoclast differentiation.

Authors:  Heather A Carey; Blake E Hildreth; Jennifer A Geisler; Mara C Nickel; Jennifer Cabrera; Sankha Ghosh; Yue Jiang; Jing Yan; James Lee; Sandeep Makam; Nicholas A Young; Giancarlo R Valiente; Wael N Jarjour; Kun Huang; Thomas J Rosol; Ramiro E Toribio; Julia F Charles; Michael C Ostrowski; Sudarshana M Sharma
Journal:  Bone Res       Date:  2018-03-28       Impact factor: 13.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.